Amrit Manik Nasta, Ramen Goel, Rishi Singhal, Luc Lemmens, Sarfaraz Baig, Yosuke Seki, Arun Prasad, Sonja Chiappetta, Mohammad Kermansaravi, Marc Vertruyen, Beniamino Pascotto, Juan Santiago Azagra, Waleed Al-Khyatt, Gennaro Martines, Diva Y Villao, Leandro Revello, Marco Rioseco, Francesco Martini, Arnaud Liagre, Gildas Juglard, Giovanni Dapri, Monika A Proczko-Stepaniak, Adel K Abou-Mrad, Hosam M Elghadban, Christine Stier, Jasper L E Van Herck, Safwan Abdulrahman Taha, Ozan Şen, Bruno Dillemans, Stijn Van Hoef, Mathieu Vandeputte, Sofie Viskens, Paolo Gentileschi, Raj Palaniappan, Nasser Sakran, Thomas H Shin, Ali Aminian, Matteo Uccelli, Stefano Olmi, Giovanni C Cesana, Marco Anselmino, Nicolas P A Debergh, Daniel Gärtner, Wah Yang, Digvijay S Bedi, Kamal Mahawar
INTRODUCTION: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of RBS. In this study, we aimed to evaluate the 30-day morbidity and mortality of RBS at participating centres. METHODS: An international steering group was formed to oversee the study. The steering group members invited bariatric surgeons worldwide to participate in this study...
2024: Obesity Research & Clinical Practice